Last update :
18/04/2024
Anticancer drug   Oxaliplatin  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Axiplatin Germany
Bendaplatin Germany
Bioezulen Brazil
Celdach Peru
Crisapla Chile, Ecuador, Venezuela
Crisatinox Turkey
Dabenzol Argentina, Ecuador
Dacplat Argentina
Eloxarin Ecuador
Eloxatin Austria, Belgium, Brazil, Chile, Colombia, Egypt, Great Britain, Iran, Italy, Luxembourg, Malaysia, Mexico, New Zealand, Norway, Peru, Portugal, Romania, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United States of America, Venezuela
Eloxatine France, Morocco, Switzerland
Entia Colombia, Mexico
Euroxaliplatine Germany
Glenoxal Peru
Goxyral Argentina, Ecuador
Kebir Argentina, Peru
Linoxa Turkey
Lisix Chile
Metaplatin Argentina
Oliptino Argentina
Onicol Chile, Peru
Oxalibbs Brazil
Oxaliplan Germany
Riboxatin Germany
Stability in solutions   Injection   Stability in solutions : Oxaliplatin     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass Water for Injection 5 mg/ml 2-8°C Protect from light
28 Day
2258
Manufacturer's stability data

Glass Glucose 5% 0,1 mg/ml 42°C Not specified
2 Hour
2791
Level of evidence B

Glass Glucose 5% 5 mg/ml 25°C Light
28 Day
2258
Manufacturer's stability data

Glass Ringer’s lactate solution 0,1 mg/ml 42°C Not specified
0.5 Hour
2791
Level of evidence B

Glass  Dianéal® PD4 1.36% glucose (Baxter) 0,1 mg/ml 42°C Not specified
0.5 Hour
2791
Level of evidence B

Polyvinyl chloride Glucose 5% 0,2 mg/ml 20°C With or without light
14 Day
2883
Level of evidence A

Polyvinyl chloride Glucose 5% 0,2 mg/ml 4°C Protect from light
14 Day
2883
Level of evidence A

Polyvinyl chloride Glucose 5% 1,3 mg/ml 20°C With or without light
14 Day
2883
Level of evidence A

Polyvinyl chloride Glucose 5% 1,3 mg/ml 4°C Protect from light
14 Day
2883
Level of evidence A

Polyethylene Glucose 5% 0,2 mg/ml 20°C With or without light
14 Day
2883
Level of evidence A

Polyethylene Glucose 5% 0,2 mg/ml 4°C Protect from light
14 Day
2883
Level of evidence A

Polyethylene Glucose 5% 1,3 mg/ml 20°C With or without light
14 Day
2883
Level of evidence A

Polyethylene Glucose 5% 1,3 mg/ml 4°C Protect from light
14 Day
2883
Level of evidence A

Polypropylene Glucose 5% 0,2 mg/ml 20°C With or without light
14 Day
2883
Level of evidence A

Polypropylene Glucose 5% 0,2 mg/ml 4°C Protect from light
14 Day
2883
Level of evidence A

Polypropylene Glucose 5% 1,3 mg/ml 20°C With or without light
14 Day
2883
Level of evidence A

Polypropylene Glucose 5% 1,3 mg/ml 4°C Protect from light
14 Day
2883
Level of evidence A

Polyolefine Glucose 5% 0,2 mg/ml 2-8°C Protect from light
28 Day
4004
Level of evidence A+

Polyolefine Glucose 5% 0,2 mg/ml 22°C Protect from light
28 Day
4004
Level of evidence A+

Polyolefine Glucose 5% 0,25 mg/ml 25°C With or without light
90 Day
2321
Level of evidence C

Polyolefine Glucose 5% 0,25 mg/ml 4°C Protect from light
90 Day
2321
Level of evidence C

Polyolefine Glucose 5% 0.7 mg/ml 20-24°C With or without light
30 Day
2207
Level of evidence A

Polyolefine Glucose 5% 0.7 mg/ml 3-7°C Protect from light
30 Day
2207
Level of evidence A

Polyolefine Glucose 5% 1 mg/ml 2-8°C Protect from light
28 Day
4004
Level of evidence A+

Polyolefine Glucose 5% 1 mg/ml 22°C Protect from light
28 Day
4004
Level of evidence A+

Polyolefine Glucose 5% 1.5 mg/ml 2-8°C Protect from light
84 Day
3670
Level of evidence A+

Not specified Glucose 5% 0.2 & 1 mg/ml 2-8°C Protect from light
4 Day
2259
Manufacturer's stability data

Not specified Glucose 5% 0.2 & 1 mg/ml 25°C Light
8 Hour
2259
Manufacturer's stability data


  Mentions Légales